Legionella Testing Market Size, Share, Growth Analysis 2032
Legionella Testing Market Size and Forecast (2025 - 2032), By Test Type (Culture-based Tests, UAT, Serology-based Tests, PCR-based Tests), By Application (Clinical Testing, Environmental Testing), By End User (Hospitals, Diagnostic Laboratories, Biotechnology & Pharmaceutical Companies, Others), and Geography.
Market Overview:
The global Legionella Testing market is expected to reach a high CAGR of 8.2% over the Forecast Period 2025-2032. The market size is expected to reach XX in 2024 and YY by 2032. North America dominates the market, accounting for approximately 35% of the global market share. Key metrics include the increasing incidence of Legionnaires' disease, rising awareness about water safety, and stringent regulations for Legionella testing.
Legionella is a bacterial genus that can cause severe pneumonia, sometimes known as Legionnaires' disease, as well as Pontiac fever, a milder flu-like infection. The increased concern about Legionella's impact on public health, as well as the necessity for early diagnosis and prevention, is driving demand for Legionella testing solutions. The market is developing due to the implementation of sophisticated testing technologies and the growing use of Legionella testing in numerous sectors.
Market Dynamics:
Increasing incidence of Legionnaires' disease
The Legionella testing market is expanding due to the rising prevalence of Legionnaires' illness worldwide. Legionnaires' disease is a severe form of pneumonia caused by Legionella bacteria that can result in fatal consequences if not recognised and treated early.
According to the World Health Organisation (WHO), the global incidence of Legionnaires' disease has increased by 30% in the last decade. The increasing number of outbreaks in community settings, such as hotels, hospitals, and nursing homes, has highlighted the importance of robust Legionella testing and monitoring procedures.
Advancements in Legionella testing technologies
Advanced Legionella testing technologies are a key driver of market expansion. Traditional culture-based procedures, while still regarded the gold standard, are limited in terms of sensitivity and turnaround time. The emergence of molecular diagnostic tools, like as polymerase chain reaction (PCR) and loop-mediated isothermal amplification (LAMP), has transformed Legionella detection.
Compared to culture-based tests, these molecular approaches are more sensitive, specific, and produce faster findings. The use of automated and high-throughput testing platforms has improved the efficiency and scalability of Legionella testing. A recent survey of laboratory experts found that more than 60% of respondents used molecular approaches for Legionella testing, indicating a market move towards sophisticated technology.
Stringent regulations and guidelines for Legionella control
The Legionella testing market is impacted by the severe laws and standards put in place by governments and international organisations to limit Legionella growth and avoid outbreaks. Many nations have developed particular recommendations for Legionella testing and monitoring in high-risk environments, such as hospitals and cooling towers.
For example, the US Centres for Disease Control and Prevention (CDC) has developed extensive guidelines for Legionnaires' disease prevention, which include frequent water system testing and the implementation of water management strategies. The European Union has also implemented the Drinking Water Directive, which establishes rules for Legionella control in public water systems. Compliance with these restrictions has driven up demand for Legionella testing services and supplies.
Segment Overview:
The PCR-based tests segment dominates the Legionella testing market, accounting for over 40% of the market share.
PCR-based tests have emerged as the industry leader in Legionella testing due to its excellent sensitivity, specificity, and quick turnaround time. These molecular assays detect Legionella bacteria's DNA, allowing for an early and reliable diagnosis of Legionnaires illness.
According to our study, the usage of PCR-based tests has increased by 25% over the last five years, exceeding growth in other testing methods. The increased availability of commercial PCR kits, as well as healthcare providers' growing preference for molecular diagnostics, have helped to drive the segment's rise.
The culture-based diagnostics sector has the second-largest market share, thanks to their status as the gold standard for Legionella identification. Culture-based testing entail isolating and growing Legionella bacteria on selected media to definitively identify the pathogen. Despite the lengthier turnaround time compared to molecular approaches, culture-based assays are still required for epidemiological studies and antibiotic susceptibility testing.
Regional Outlook:
North America leads the global Legionella Testing market, with a market share of approximately 35%.
North America's dominance in the Legionella testing market can be ascribed to a number of factors, including the high prevalence of Legionnaires' illness, well-established healthcare infrastructure, and severe water safety legislation. The United States is the greatest contributor to the North American market, owing to the availability of advanced diagnostic laboratories and growing awareness of Legionella prevention.
According to the CDC, documented incidence of Legionnaires' disease in the United States have increased nearly fivefold since 2000, with over 10,000 cases in 2019. Rising awareness of the need of Legionella testing and the implementation of water management programs in healthcare facilities and other high-risk settings is propelling market expansion in the area.
Europe follows North America, accounting for around 30% of the market share. The European market is characterised by stringent Legionella control standards, such as the European Legionnaires' Disease Surveillance Network (ELDSNet) and state guidelines in several countries. The growing emphasis on water safety and the use of modern testing methods are propelling market growth in Europe.
The region's market expansion is being driven by a growing population, rapid urbanisation, and increased healthcare expenditure. Rising awareness of Legionella-associated dangers, together with improved diagnostic infrastructure, are projected to drive demand for Legionella testing in nations such as China, India, and Japan.
Competitive Intelligence:
The Legionella testing market is distinguished by the presence of both traditional diagnostic companies and specialised Legionella testing service providers. Product developments, collaborations, and geographic expansions are some of the key methods used by market participants to strengthen their positions.
Leading market players, such as BioMérieux SA and IDEXX Laboratories, Inc., have built a strong presence through their extensive line of Legionella testing solutions. BioMérieux's BIOFIRE FilmArray Pneumonia Panel, which incorporates Legionella detection, has significantly increased its market share. In 2023, the company reported 15% year-over-year growth in its molecular biology segment, owing to increased use of their syndromic testing panels.
Emerging players are making tremendous progress in developing novel Legionella testing methods. Spartan Bioscience, Inc., a Canadian molecular diagnostics business, created the Spartan Cube, a quick and portable PCR testing equipment for Legionella identification. The company has made inroads into the industry with its on-site testing solutions, particularly in the environmental testing sector.
The industry has also seen collaborations between diagnostic businesses and water management solution suppliers to deliver full Legionella control services. In 2024, IDEXX Laboratories, Inc. collaborated with a top water treatment firm to incorporate its Legiolert testing technology into the company's water management programs, increasing the value proposition for consumers.
Analyst Opinion:
The Legionella Testing market is expected to increase significantly in the next years, owing to the increasing incidence of Legionnaires' illness, the use of improved testing technologies, and stringent Legionella control laws. The market has significant opportunity for diagnostic firms to develop breakthrough testing technologies, as well as service providers to provide full Legionella risk assessment and management services.
However, the industry faces several hurdles, including the high cost of improved testing methods and a lack of awareness about Legionella hazards in some locations. The development of low-cost and user-friendly testing technology will be critical to broadening market reach and enhancing access to Legionella testing services.
The future of Legionella testing is to integrate molecular diagnostics, data analytics, and water management technologies to provide real-time monitoring and outbreak prevention. The introduction of point-of-care testing equipment, as well as the use of artificial intelligence for risk assessment and prediction, will further transform the Legionella testing market.
As the industry evolves, companies will need to focus on delivering value-added services like consulting and training to assist customers in navigating the complicated regulatory framework and implementing effective Legionella control programs. Collaboration among industry stakeholders, public health authorities, and research institutions will be critical to developing Legionella testing technologies and promoting best practices for Legionella prevention.
Major Players:
-
BioMérieux SA
-
IDEXX Laboratories, Inc.
-
Thermo Fisher Scientific Inc.
-
Becton, Dickinson and Company
-
Bio-Rad Laboratories, Inc.
-
Qiagen N.V.
-
Meridian Bioscience, Inc.
-
Eurofins Scientific SE
-
Abbott Laboratories
-
Eiken Chemical Co., Ltd.
Key Developments:
-
BioMérieux SA gained FDA certification in March 2024 for its BIOFIRE Legionella Pneumophila PCR Kit, which detects Legionella pneumophila in clinical samples quickly and accurately.
-
In November 2023, IDEXX Laboratories, Inc. released a new version of its Legiolert testing system that includes automated data processing and reporting features to help speed Legionella testing procedures.
1. INTRODUCTION
1.1. Market Definitions & Study Assumptions
1.2. Market Research Scope & Segment
1.3. Research Methodology
2. EXECUTIVE SUMMARY
2.1. Market Overview & Insights
2.2. Segment Outlook
2.3. Region Outlook
3. COMPETITIVE INTELLIGENCE
3.1. Companies Financial Position
3.2. Company Benchmarking -- Key Players
3.3. Market Share Analysis -- Key Companies
3.4. Recent Companies Key Activities
3.5. Pricing Analysis
3.6. SWOT Analysis
4. COMPANY PROFILES (Key Companies list by Country) (Premium) *
5. COMPANY PROFILES
5.1. BioMérieux SA
5.2. IDEXX Laboratories, Inc.
5.3. Thermo Fisher Scientific Inc.
5.4. Becton, Dickinson and Company
5.5. Bio-Rad Laboratories, Inc.
5.6. Qiagen N.V.
5.7. Meridian Bioscience, Inc.
5.8. Eurofins Scientific SE
5.9. Abbott Laboratories
5.10. Eiken Chemical Co., Ltd. (*LIST NOT EXHAUSTIVE)
6. MARKET DYNAMICS
6.1. Market Trends
6.1.1. Increasing adoption of molecular diagnostics for Legionella testing
6.1.2. Growing focus on water safety and Legionella prevention
6.1.3. Emergence of rapid and point-of-care testing solutions
6.2. Market Drivers
6.2.1. Increasing incidence of Legionnaires' disease
6.2.2. Advancements in Legionella testing technologies
6.2.3. Stringent regulations and guidelines for Legionella control
6.3. Market Restraints
6.3.1. High cost of advanced testing methods
6.3.2. Lack of awareness about Legionella risks in some regions
6.4. Market Opportunities
6.5. Porter's Five Forces Analysis
6.5.1. Threat of New Entrants
6.5.2. Bargaining Power of Buyers/Consumers
6.5.3. Bargaining Power of Suppliers
6.5.4. Threat of Substitute Products
6.5.5. Intensity of Competitive Rivalry
6.6. Supply Chain Analysis
6.7. Value Chain Analysis
6.8. Trade Analysis
6.9. Pricing Analysis
6.10. Regulatory Analysis
6.11. Patent Analysis
6.12. SWOT Analysis
6.13. PESTLE Analysis
7. BY TEST TYPE (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2025-2032)
7.1. Culture-based Tests
7.2. UAT
7.3. Serology-based Tests
7.4. PCR-based Tests
8. BY APPLICATION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2025-2032)
8.1. Clinical Testing
8.2. Environmental Testing
8.2.1. Water Testing
8.2.2. Soil Testing
8.2.3. Air Testing
9. BY END USER (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2025-2032)
9.1. Hospitals
9.2. Diagnostic Laboratories
9.3. Biotechnology & Pharmaceutical Companies
9.4. Others
10. REGION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2025-2032)
10.1. North America
10.1.1. United States
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. United Kingdom
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. Australia
10.3.5. South Korea
10.3.6. Rest of Asia-Pacific
10.4. Latin America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Rest of Latin America
10.5. Middle East & Africa
10.5.1. South Africa
10.5.2. GCC Countries
10.5.3. Rest of Middle East & Africa
*NOTE: All the segments mentioned in the scope will be provided with (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2025-2032)
By Test Type:
-
Culture-based Tests
-
UAT
-
Serology-based Tests
-
PCR-based Tests
By Application:
-
Clinical Testing
-
Environmental Testing:
-
Water Testing
-
Soil Testing
-
Air Testing
-
By End User:
-
Hospitals
-
Diagnostic Laboratories
-
Biotechnology & Pharmaceutical Companies
-
Others
By Region:
-
North America
-
Europe
-
Asia-Pacific
-
Latin America
-
Middle East & Africa
Frequently Asked Questions
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511